The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

SureCN211612     2,5- diazabicyclo[5.4.0]undeca- 3,5,7,9,11...

Synonyms: SureCN2301093, CHEBI:38431, CTK1A7566, AC1L3X3N, 264-64-2, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of 1,4-Benzodiazepine


Psychiatry related information on 1,4-Benzodiazepine


High impact information on 1,4-Benzodiazepine


Biological context of 1,4-Benzodiazepine


Anatomical context of 1,4-Benzodiazepine


Associations of 1,4-Benzodiazepine with other chemical compounds


Gene context of 1,4-Benzodiazepine


Analytical, diagnostic and therapeutic context of 1,4-Benzodiazepine


  1. Attenuation of autoimmune disease in Fas-deficient mice by treatment with a cytotoxic benzodiazepine. Bednarski, J.J., Warner, R.E., Rao, T., Leonetti, F., Yung, R., Richardson, B.C., Johnson, K.J., Ellman, J.A., Opipari, A.W., Glick, G.D. Arthritis Rheum. (2003) [Pubmed]
  2. Identification and validation of the mitochondrial F1F0-ATPase as the molecular target of the immunomodulatory benzodiazepine Bz-423. Johnson, K.M., Chen, X., Boitano, A., Swenson, L., Opipari, A.W., Glick, G.D. Chem. Biol. (2005) [Pubmed]
  3. Open study of clobazam in refractory epilepsy. Munn, R., Farrell, K. Pediatric neurology. (1993) [Pubmed]
  4. Mechanism of action of clonazepam in myoclonus in relation to effects on GABA and 5-HT. Jenner, P., Pratt, J.A., Marsden, C.D. Advances in neurology. (1986) [Pubmed]
  5. Testicular toxicity induced by oral administration of SC-32855, A 1,4-benzodiazepine, in the dog. Means, J.R., Chengelis, C.P., Jasty, V. Res. Commun. Chem. Pathol. Pharmacol. (1982) [Pubmed]
  6. Loprazolam. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in insomnia. Clark, B.G., Jue, S.G., Dawson, G.W., Ward, A. Drugs (1986) [Pubmed]
  7. Benzodiazepine-induced superoxide signals B cell apoptosis: mechanistic insight and potential therapeutic utility. Blatt, N.B., Bednarski, J.J., Warner, R.E., Leonetti, F., Johnson, K.M., Boitano, A., Yung, R., Richardson, B.C., Johnson, K.J., Ellman, J.A., Opipari, A.W., Glick, G.D. J. Clin. Invest. (2002) [Pubmed]
  8. The proapoptotic benzodiazepine Bz-423 affects the growth and survival of malignant B cells. Boitano, A., Ellman, J.A., Glick, G.D., Opipari, A.W. Cancer Res. (2003) [Pubmed]
  9. Novel, achiral 1,3,4-benzotriazepine analogues of 1,4-benzodiazepine-based CCK(2) antagonists that display high selectivity over CCK(1) receptors. McDonald, I.M., Austin, C., Buck, I.M., Dunstone, D.J., Griffin, E., Harper, E.A., Hull, R.A., Kalindjian, S.B., Linney, I.D., Low, C.M., Pether, M.J., Spencer, J., Wright, P.T., Adatia, T., Bashall, A. J. Med. Chem. (2006) [Pubmed]
  10. Clonazepam in the treatment of patients with recurrent panic attacks. Beaudry, P., Fontaine, R., Chouinard, G., Annable, L. The Journal of clinical psychiatry. (1986) [Pubmed]
  11. Sequentially labile water-soluble prodrugs of alprazolam. Cho, M.J., Sethy, V.H., Haynes, L.C. J. Med. Chem. (1986) [Pubmed]
  12. Peptidoaminobenzophenones, a novel class of ring-opened derivatives of 1,4-benzoidazepines. Hirai, K., Ishiba, T., Sugimoto, H., Sasakura, K., Fujishita, T., Toyoda, T., Tsukinoki, Y., Joyama, H., Hatakeyama, H., Hirose, K. J. Med. Chem. (1980) [Pubmed]
  13. Autoradiography of benzodiazepine receptor binding in the central nervous system of the normal C57BL6J mouse. Biscoe, T.J., Fry, J.P., Rickets, C. J. Physiol. (Lond.) (1984) [Pubmed]
  14. A comparative pharmacokinetic study of intravenous and intramuscular midazolam in patients with epilepsy. Bell, D.M., Richards, G., Dhillon, S., Oxley, J.R., Cromarty, J., Sander, J.W., Patsalos, P.N. Epilepsy Res. (1991) [Pubmed]
  15. The behavior of 1,4-benzodiazepine drugs in acidic media. II. Kinetics and mechanism of the acid-base equilibrium reaction of oxazolam. Kurono, Y., Kuwayama, T., Kamiya, K., Yashiro, T., Ikeda, K. Chem. Pharm. Bull. (1985) [Pubmed]
  16. RO5-4864 inhibits the binding of [35S]t-butylbicyclophosphorothionate to rat brain membranes. Ticku, M.K., Ramanjaneyulu, R. Life Sci. (1984) [Pubmed]
  17. Changes in benzodiazepine receptor binding as seen autoradiographically in the central nervous system of the spastic mouse. Biscoe, T.J., Fry, J.P., Rickets, C. J. Physiol. (Lond.) (1984) [Pubmed]
  18. Studies on a novel, potent and orally effective cholecystokinin A antagonist, FK-480. Synthesis and structure-activity relationships of FK-480 and related compounds. Satoh, Y., Matsuo, T., Sogabe, H., Itoh, H., Tada, T., Kinoshita, T., Yoshida, K., Takaya, T. Chem. Pharm. Bull. (1994) [Pubmed]
  19. Transfer of metaclazepam and its metabolites into breast milk. Schotter, A., Müller, R., Günther, C., Hausleiter, H.J., Achtert, G. Arzneimittel-Forschung. (1989) [Pubmed]
  20. Oxprenolol plus ethanol causes no central nervous system depression--a comparison with lorazepam plus ethanol. Aucamp, A.K., Weis, O.F., Müller, F.O., Gill, C.E., Malan, J. S. Afr. Med. J. (1984) [Pubmed]
  21. Evaluation of temazepam as a hypnotic. Mitler, M.M. Pharmacotherapy (1981) [Pubmed]
  22. Midazolam: the first water-soluble benzodiazepine. Pharmacology, pharmacokinetics and efficacy in insomnia and anesthesia. Kanto, J.H. Pharmacotherapy (1985) [Pubmed]
  23. Peptide/benzodiazepine hybrids as ligands of CCK(A) and CCK(B) receptors. Escherich, A., Lutz, J., Escrieut, C., Fourmy, D., van Neuren, A.S., Müller, G., Schafferhans, A., Klebe, G., Moroder, L. Biopolymers (2000) [Pubmed]
  24. Benzimidazole derivatives as arginine mimetics in 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonists. Keenan, R.M., Miller, W.H., Lago, M.A., Ali, F.E., Bondinell, W.E., Callahan, J.F., Calvo, R.R., Cousins, R.D., Hwang, S.M., Jakas, D.R., Ku, T.W., Kwon, C., Nguyen, T.T., Reader, V.A., Rieman, D.J., Ross, S.T., Takata, D.T., Uzinskas, I.N., Yuan, C.C., Smith, B.R. Bioorg. Med. Chem. Lett. (1998) [Pubmed]
  25. An enzyme immunoassay for a metabolite of a new sleep inducer (450191-S), a ring-opened derivative of 1,4-benzodiazepine, in human serum. Kominami, G., Matsumoto, H., Nakamura, M., Kono, M. Journal of immunoassay. (1987) [Pubmed]
  26. Development of 1,4-benzodiazepine cholecystokinin type B antagonists. Bock, M.G., DiPardo, R.M., Evans, B.E., Rittle, K.E., Whitter, W.L., Garsky, V.M., Gilbert, K.F., Leighton, J.L., Carson, K.L., Mellin, E.C. J. Med. Chem. (1993) [Pubmed]
  27. CoMFA and CoMSIA 3D-quantitative structure-activity relationship model on benzodiazepine derivatives, inhibitors of phosphodiesterase IV. Ducrot, P., Andrianjara, C.R., Wrigglesworth, R. J. Comput. Aided Mol. Des. (2001) [Pubmed]
  28. 1,4-Benzodiazepine peripheral cholecystokinin (CCK-A) receptor agonists. Sherrill, R.G., Berman, J.M., Birkemo, L., Croom, D.K., Dezube, M., Ervin, G.N., Grizzle, M.K., James, M.K., Johnson, M.F., Queen, K.L., Rimele, T.J., Vanmiddlesworth, F., Sugg, E.E. Bioorg. Med. Chem. Lett. (2001) [Pubmed]
  29. Discovery of an imidazopyridine-containing 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonist with efficacy in a restenosis model. Keenan, R.M., Lago, M.A., Miller, W.H., Ali, F.E., Cousins, R.D., Hall, L.B., Hwang, S.M., Jakas, D.R., Kwon, C., Louden, C., Nguyen, T.T., Ohlstein, E.H., Rieman, D.J., Ross, S.T., Samanen, J.M., Smith, B.R., Stadel, J., Takata, D.T., Vickery, L., Yuan, C.C., Yue, T.L. Bioorg. Med. Chem. Lett. (1998) [Pubmed]
  30. Structure activity studies of a novel cytotoxic benzodiazepine. Boitano, A., Emal, C.D., Leonetti, F., Blatt, N.B., Dineen, T.A., Ellman, J.A., Roush, W.R., Opipari, A.W., Glick, G.D. Bioorg. Med. Chem. Lett. (2003) [Pubmed]
  31. Stereochemical aspects of benzodiazepine binding to human serum albumin. I. Enantioselective high performance liquid affinity chromatographic examination of chiral and achiral binding interactions between 1,4-benzodiazepines and human serum albumin. Noctor, T.A., Pham, C.D., Kaliszan, R., Wainer, I.W. Mol. Pharmacol. (1992) [Pubmed]
  32. A critical evaluation of the application of capillary electrophoresis to the detection and determination of 1,4-benzodiazepine tranquilizers in formulations and body materials. Smyth, W.F., McClean, S. Electrophoresis (1998) [Pubmed]
  33. Separation, isolation and identification of optical isomers of 1,4-benzodiazepine glucuronides from biological fluids by reversed-phase high-performance liquid chromatography. Mascher, H., Nitsche, V., Schütz, H. J. Chromatogr. (1984) [Pubmed]
  34. Determination of an oxadiazole-substituted 1,4-benzodiazepine in plasma by high-performance liquid chromatography with ultraviolet detection and by a radioreceptor assay. Nordholm, L., Mengel, H. J. Chromatogr. (1989) [Pubmed]
  35. Pharmacokinetics and sedative effect of midazolam in connection with caesarean section performed under epidural analgesia. Kanto, J., Aaltonen, L., Erkkola, R., Aärimaa, L. Acta anaesthesiologica Scandinavica. (1984) [Pubmed]
WikiGenes - Universities